# Notice of Intent to Sole Source – CARDINAL HEALTH 414, LLC– radiopharmaceuticals Canonical: https://abierto.us/opportunities/noiod27000001 - Solicitation number: NOI-OD-27-000001 - Notice type: Presolicitation - Status: Closed. Deadline was October 19, 2026 at 12:00 PM EDT - Department: Department of Health and Human Services - Agency: National Institutes of Health - Contracting office: National Institutes of Health Olao (75N980) - NAICS: 325412 Pharmaceutical Preparation Manufacturing - Product or service code: 3650 Chemical and Pharmaceutical Products Manufacturing Machinery - Place of performance: Bethesda, Maryland - Who can bid, by location: Anywhere in the US. Location does not limit who can bid: a product shipped to the buyer, research at the performer's facility, or work at the contractor's site. A state shown is the delivery point. - County: Montgomery County (FIPS 24031). https://abierto.us/counties/montgomery-county-md-24031 - City: Bethesda. https://abierto.us/cities/bethesda-md-2407125 - First posted: October 13, 2026 - Last posted: October 13, 2026 - SAM.gov: https://sam.gov/workspace/contract/opp/8feb133f7d0241febaacc4a342ad1e25/view ## Description This is a notice of intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested. This procurement is for a purchase order NTE $900,000 for FDA-approved radiopharmaceuticals for patient care by the Nuclear Medicine Division, Department of Radiology and Imaging Sciences at the NIH Clinical Center. CARDINAL HEALTH is a reputed and reliable FDA and US NRC vetted supplier of the required radiopharmaceuticals by the Clinical Center. Based on the past 25 years of contracting with this vendor, this vendor is the only acceptable vendor because they provide a comprehensive list of radiopharmaceuticals that uniquely meets the patient needs of the NIH Clinical Center. They are the only provider that can supply all radiopharmaceuticals that emit gamma, positrons, beta and/or alpha radiations. They also use a patented tungsten delivery system for dispensing the high energy positron radiopharmaceuticals. This system minimizes radiation exposure to the staff and the public, as well as meeting the weight standard that reduces the potential weightlifting injuries to the staff. This acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 –Simplified Acquisition Procedures, Subpart 13.500 This subpart authorizes the use of simplified procedures for the acquisition of supplies and services in amounts greater than the simplified acquisition threshold but not exceeding $9 million ($15 million for acquisitions as described in 13.500(c)), including options, if the contracting officer reasonably expects, based on the nature of the supplies or services sought, and on market research, that offers will include only commercial products or commercial services. Contracting officers may use any simplified acquisition procedure in this part, subject to any specific dollar limitation applicable to the particular procedure. Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements. Comments to this announcement, referencing this posting number, may be submitted to the NIH, Clinical Center, Office of Purchasing and Contracts, prior to the closing date specified in this announcement, to the attention of Ryssa Nix, Contract Specialist via email to Ryssa.nix@nih.gov by close date. Notice Type: Notice of Intent NAICS Code: 325412 PSC Code: 3650 Posted Date: 10/13/2026 Close Date: 10/19/2026 12pm EST End User IC: Clinical Center POC Name: Ryssa Nix Email Address: Ryssa.nix@nih.gov ## Attachments - [NOI to sole source above SAT.docx](https://sam.gov/api/prod/opps/v3/opportunities/resources/files/df0b2914b257419c9b9b910de5c1fe9d/download) ## Open now in the same industry 9 open in NAICS 325412. - FY27 Low Energy General Radiopharmaceuticals 36C25027Q0052 (36C25027Q0052), due November 3, 2026 at 9:00 AM EST. https://abierto.us/opportunities/36c25027q0052 - Sacubitril/Valsartan Tablets (VA-27-00014055) (36E79727R0007), due November 3, 2026 at 3:30 PM EST. https://abierto.us/opportunities/36e79727r0007 - LIDOCAINE 5% PATCHES-REQUEST FOR INFORMATION (36C77027Q0010), due November 3, 2026 at 6:00 PM EST. https://abierto.us/opportunities/36c77027q0010 ## Publications - October 13, 2026: Presolicitation, due October 19, 2026 at 12:00 PM EDT. Notice 8feb133f7d0241febaacc4a342ad1e25. https://sam.gov/workspace/contract/opp/8feb133f7d0241febaacc4a342ad1e25/view ## Points of contact - Chris Ryssa Nix, ryssa.nix@nih.gov --- Source: SAM.gov Contract Opportunities bulk extract. Confirm deadlines on SAM.gov before responding. Cite https://abierto.us/opportunities/noiod27000001.